Atlas Trials

Methylene Blue Treatment of COVID-19

Clinical trial NCT04635605 · COMPLETED

Trial details

NCT number
NCT04635605
Sponsor
Fondazione Epatocentro Ticino
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
SARS-CoV2
Start date
2020-11-05
Primary completion
2021-08-13
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.